RFP Human Pulmonary Microvascular Endothelial Cells

Human Pulmonary Microvascular Endothelial Cells engineered to express Red Fluorescent Protein (RFP) are a specialized type of human lung microvascular endothelial cells. These cells have been genetically modified to stably produce RFP, which emits a bright red fluorescence under specific lighting conditions. This unique characteristic makes them an invaluable tool for various scientific applications.

Researchers can utilize these RFP-expressing cells to conduct detailed fluorescent imaging, allowing for the visualization of cellular processes in real-time. They are instrumental in studies focused on endothelial biology, as they help elucidate the complex behaviors and functions of endothelial cells within the lung's microvascular network. Moreover, these cells are widely used in angiogenesis assays to study the formation of new blood vessels, as well as in experiments assessing barrier function, which is crucial for understanding vascular permeability and related diseases.

Additionally, these cells serve as models for investigating inflammation, providing insights into how endothelial cells respond to inflammatory stimuli. Overall, the RFP-expressing human pulmonary microvascular endothelial cells are essential tools in lung vascular research, enhancing our understanding of various physiological and pathological processes in the respiratory system.

IMPORTANT: Quality warranty requires use of NeoBioPharma media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.